Nanosized Drug Delivery Systems to Fight Tuberculosis
Tuberculosis (TB) is currently the second deadliest infectious disease. Existing antitubercular therapies are long, complex, and have severe side effects that result in low patient compliance. In this context, nanosized drug delivery systems (DDSs) have the potential to optimize the treatment's...
Saved in:
Main Authors: | Tom Bourguignon (Author), Jesus Alfredo Godinez-Leon (Author), Ruxandra Gref (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota
by: Michail Karavolos, et al.
Published: (2016) -
Nanosized Drug Delivery Systems: Colloids and Gels for Site Specific Targeting
Published: (2020) -
IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
by: Amir R. Jalilian, et al.
Published: (2022) -
Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations
by: Jibira Yakubu, et al.
Published: (2024) -
Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy
by: Rudzińska M, et al.
Published: (2021)